These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 22336820)

  • 21. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drospirenone: a novel progestin.
    Rapkin AJ; Winer SA
    Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Types of progestogens in combined oral contraception: effectiveness and side-effects.
    Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
    Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
    Shehata NAA; Moety GAFA; El Wahed HAA; Fahim AS; Katta MA; Hussein GK
    Reprod Sci; 2020 Feb; 27(2):743-750. PubMed ID: 32046452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
    Yonkers KA; Brown C; Pearlstein TB; Foegh M; Sampson-Landers C; Rapkin A
    Obstet Gynecol; 2005 Sep; 106(3):492-501. PubMed ID: 16135578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined oral contraceptives: venous thrombosis.
    de Bastos M; Stegeman BH; Rosendaal FR; Van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010813. PubMed ID: 24590565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestin-only pills for contraception.
    Grimes DA; Lopez LM; O'Brien PA; Raymond EG
    Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quadriphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA; Raps M; Lopez LM; Helmerhorst FM
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009038. PubMed ID: 22071862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YAZ in the treatment of premenstrual dysphoric disorder.
    Rapkin AJ
    J Reprod Med; 2008 Sep; 53(9 Suppl):729-41. PubMed ID: 18980045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
    Guang-Sheng F; Mei-Lu B; Li-Nan C; Xiao-Ming C; Zi-Rong H; Zi-Yan H; Xiao-Ping J; Jian L; Shu-Ying W; Cheng-Liang X; Zheng-Ai X; Tian-Fu Y
    Clin Drug Investig; 2010; 30(6):387-96. PubMed ID: 20201608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupuncture and acupressure for premenstrual syndrome.
    Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
    Pearlstein TB; Bachmann GA; Zacur HA; Yonkers KA
    Contraception; 2005 Dec; 72(6):414-21. PubMed ID: 16307962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.
    Jespersen C; Lauritsen MP; Frokjaer VG; Schroll JB
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD001396. PubMed ID: 39140320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen.
    Marr J; Niknian M; Shulman LP; Lynen R
    Contraception; 2011 Jul; 84(1):81-6. PubMed ID: 21664515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.